Akebia Therapeutics
AKBA
#6763
Rank
โ‚น41.85 B
Marketcap
โ‚น160.23
Share price
-2.59%
Change (1 day)
21.67%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -โ‚น5.85 Billion

According to Akebia Therapeutics's latest financial reports the company's current earnings are โ‚น0.16 Billion. a decrease over its 2023 earnings that were of -โ‚น4.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น5.92 Billion33.68%
2023 -โ‚น4.43 Billion-45.12%
2022 -โ‚น8.07 Billion-66.55%
2021 -โ‚น24.11 Billion-26.24%
2020 -โ‚น32.69 Billion33.94%
2019 -โ‚น24.4 Billion66.52%
2018 -โ‚น14.66 Billion123.53%
2017 -โ‚น6.56 Billion-43.34%
2016 -โ‚น11.57 Billion123.58%
2015 -โ‚น5.18 Billion63.95%
2014 -โ‚น3.16 Billion181.24%
2013 -โ‚น1.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น392.81 B-6,740.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.162 T-19,751.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น1.486 T-25,228.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.16 Billion 71.73%๐Ÿ‡บ๐Ÿ‡ธ USA